Cargando…

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol

BACKGROUND: The basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (COS) can be used as effective predictors of outcomes in women...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shen, Xu, Huihui, Wu, Xian, Xia, Lan, Li, Jian, Zhang, Dan, Zhang, Aijun, Xu, Bufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922742/
https://www.ncbi.nlm.nih.gov/pubmed/36793280
http://dx.doi.org/10.3389/fendo.2023.1093954
_version_ 1784887592627470336
author Zhao, Shen
Xu, Huihui
Wu, Xian
Xia, Lan
Li, Jian
Zhang, Dan
Zhang, Aijun
Xu, Bufang
author_facet Zhao, Shen
Xu, Huihui
Wu, Xian
Xia, Lan
Li, Jian
Zhang, Dan
Zhang, Aijun
Xu, Bufang
author_sort Zhao, Shen
collection PubMed
description BACKGROUND: The basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (COS) can be used as effective predictors of outcomes in women undergoing in vitro fertilization (IVF) treatment using the gonadotropin releasing hormone antagonist (GnRH-ant) protocol. METHODS: A total of 1,681 women undergoing their first GnRH-ant protocol were enrolled in this retrospective cohort study. A Poisson regression model was used to analyze the association between the FSH/LH ratios during COS and embryological outcomes. Receiver operating characteristic analysis was performed to determine the optimal cutoff values for poor responders (≤ 5 oocytes) or poor reproductive potential (≤ 3 available embryos). A nomogram model was constructed to provide a tool for predicting the cycle outcomes of individual IVF treatments. RESULTS: The FSH/LH ratios (at the basal day, stimulation day 6 (SD6) and trigger day) were significantly correlated with the embryological outcomes. The basal FSH/LH ratio was the most reliable predictor of poor responders with a cutoff value of 1.875 (area under the curve (AUC) = 72.3%, P < 0.05), or of poor reproductive potential with a cutoff value of 2.515 (AUC = 66.3%, P < 0.05). The SD6 FSH/LH ratio predicted poor reproductive potential with a cutoff value of 4.14 (AUC = 63.8%, P < 0.05). The trigger day FSH/LH ratio predicted poor responders with a cutoff value of 9.665 (AUC = 63.1%, P < 0.05). The basal FSH/LH ratio, combined with the SD6 and trigger day FSH/LH ratios, slightly increased these AUC values and improved the prediction sensitivity. The nomogram provides a reliable model with which to assess the risk of poor response or poor reproductive potential directly based on the combined indicators. CONCLUSIONS: FSH/LH ratios are useful predictors of poor ovarian response or reproductive potential throughout the entire COS with the GnRH antagonist protocol. Our findings also provide insights into the potential for LH supplementation and regimen adjustment during COS to achieve improved outcomes.
format Online
Article
Text
id pubmed-9922742
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99227422023-02-14 The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol Zhao, Shen Xu, Huihui Wu, Xian Xia, Lan Li, Jian Zhang, Dan Zhang, Aijun Xu, Bufang Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The basal follicle stimulating hormone (FSH)/luteinizing hormone (LH) ratio is a useful predictor of ovarian response. In this study, we investigated whether the FSH/LH ratios during the entire controlled ovarian stimulation (COS) can be used as effective predictors of outcomes in women undergoing in vitro fertilization (IVF) treatment using the gonadotropin releasing hormone antagonist (GnRH-ant) protocol. METHODS: A total of 1,681 women undergoing their first GnRH-ant protocol were enrolled in this retrospective cohort study. A Poisson regression model was used to analyze the association between the FSH/LH ratios during COS and embryological outcomes. Receiver operating characteristic analysis was performed to determine the optimal cutoff values for poor responders (≤ 5 oocytes) or poor reproductive potential (≤ 3 available embryos). A nomogram model was constructed to provide a tool for predicting the cycle outcomes of individual IVF treatments. RESULTS: The FSH/LH ratios (at the basal day, stimulation day 6 (SD6) and trigger day) were significantly correlated with the embryological outcomes. The basal FSH/LH ratio was the most reliable predictor of poor responders with a cutoff value of 1.875 (area under the curve (AUC) = 72.3%, P < 0.05), or of poor reproductive potential with a cutoff value of 2.515 (AUC = 66.3%, P < 0.05). The SD6 FSH/LH ratio predicted poor reproductive potential with a cutoff value of 4.14 (AUC = 63.8%, P < 0.05). The trigger day FSH/LH ratio predicted poor responders with a cutoff value of 9.665 (AUC = 63.1%, P < 0.05). The basal FSH/LH ratio, combined with the SD6 and trigger day FSH/LH ratios, slightly increased these AUC values and improved the prediction sensitivity. The nomogram provides a reliable model with which to assess the risk of poor response or poor reproductive potential directly based on the combined indicators. CONCLUSIONS: FSH/LH ratios are useful predictors of poor ovarian response or reproductive potential throughout the entire COS with the GnRH antagonist protocol. Our findings also provide insights into the potential for LH supplementation and regimen adjustment during COS to achieve improved outcomes. Frontiers Media S.A. 2023-01-30 /pmc/articles/PMC9922742/ /pubmed/36793280 http://dx.doi.org/10.3389/fendo.2023.1093954 Text en Copyright © 2023 Zhao, Xu, Wu, Xia, Li, Zhang, Zhang and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Zhao, Shen
Xu, Huihui
Wu, Xian
Xia, Lan
Li, Jian
Zhang, Dan
Zhang, Aijun
Xu, Bufang
The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
title The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
title_full The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
title_fullStr The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
title_full_unstemmed The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
title_short The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
title_sort serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922742/
https://www.ncbi.nlm.nih.gov/pubmed/36793280
http://dx.doi.org/10.3389/fendo.2023.1093954
work_keys_str_mv AT zhaoshen theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT xuhuihui theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT wuxian theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT xialan theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT lijian theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT zhangdan theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT zhangaijun theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT xubufang theserumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT zhaoshen serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT xuhuihui serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT wuxian serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT xialan serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT lijian serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT zhangdan serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT zhangaijun serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol
AT xubufang serumfolliclestimulatinghormonetoluteinizinghormoneratioscanpredictassistedreproductivetechnologyoutcomesinwomenundergoinggonadotropinreleasinghormoneantagonistprotocol